A recent study found that GLP-1 drugs could be manufactured for less than $5 a month
Learn more: nice.org.uk/news/article/n #NICENews Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service
The February 2026 FDA warning letter what it does and doesnt mean On February 20, 2026, the FDA issued a warning letter to MEDVi, LLC, citing marketing language on its medvi.io site
Kar M, Mishra D, Catalase
This delayed and inadequate labeling forms the basis for failure-to-warn claims, which argue that had patients and doctors received proper warnings about gastroparesis and vision loss risks, many would have chosen alternative diabetes medications or weight loss treatments
These alternatives demonstrate superior safety profiles and patient satisfaction compared to IV administration